NAFLD, non-alcoholic fatty liver disease; NLR, neutrophil-to-lymphocyte ratio; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamate pyruvate transaminase; MTX, methotrexate; ML, machine learning. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.